ArticleGalen medical journal2024
Evaluation of Changes in Hemorheological Variables in Multiple Sclerosis Patients.
Article in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultiple sclerosis (MS) is a neurodegenerative condition primarily attributed to immune system dysregulation. However, emerging evidence suggests that additional factors, such as neurodegeneration independent of immune processes, may also contribute to MS pathology. Given the significant cerebral hypoperfusion observed in MS patients from the early to advanced stages of the disease, investigating hemorheology or blood rheology, which involves studying blood flow properties and plasma protein compounds, can contribute to understanding the underlying pathology of MS. This study aims to evaluate changes in hemorheological variables in MS patients, which may offer a better understanding of the disease's progression and its impact on blood flow dynamics. MATERIALS AND
methodsIn this study, we assessed the modifications in key factors impacting hemorheology in articles related to MS. Some keywords including MS, Blood Viscosity, Hemorheology, and brain perfusion were searched in PubMed, Google Scholar, and Scopus. The searches were limited to studies published in English languages from 2000 to 2023.
resultsAmong the 110 articles found in the search, finally, 35 articles were included in the review. In some studies, patients with MS were examined for rheological blood properties and demonstrated an appreciable increase in blood viscosity. Furthermore, declines in cerebral blood volume and cerebral blood flow in MS are linked to the deterioration of physical disability. In our investigation, we focused on the key factors influencing hemorheology and examined their variations in the articles about patients with MS.
conclusionThe reduction of tissue blood perfusion caused by changes in blood hemorheology can be considered as one of the causes of the development or exacerbation of MS, but to estimate hemorheological changes in MS, we need to conduct more detailed studies on humans, which we hope will provide new solutions for the therapists of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.